VivoSim Labs (VIVS) Interest & Investment Income (2012 - 2026)
VivoSim Labs (VIVS) posted Interest & Investment Income of $28000.0 for Q2 2026, down 22.22% on a QoQ basis from $36000.0 in Q1 2026, and down 63.16% year-over-year from $76000.0 in Q2 2025.
Powered by 
Analysis
VivoSim Labs (VIVS) Interest & Investment Income (2012 - 2026) Analysis & Trends
VivoSim Labs has reported Interest & Investment Income for 15 years, with the latest figure at $28000.0 in Q2 2026.
- On a quarterly basis, Interest & Investment Income fell 63.16% year-over-year to $28000.0 in Q2 2026; TTM through Jun 2026 was $219000.0, a 27.33% increase from a year earlier, with the FY2026 full-year figure at $267000.0, up 90.71% from the prior year.
- Interest & Investment Income was $28000.0 for Q2 2026 at VivoSim Labs, down from $36000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $177000.0 in Q1 2023, with the low at $2000.0 in Q1 2022.
- Average Interest & Investment Income over 5 years is $72000.0, with a median of $61000.0 recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income soared 8750.0% in 2023, then tumbled 78.43% in 2025.
- Over 5 years, Interest & Investment Income stood at $143000.0 in 2022, then sank by 46.85% to $76000.0 in 2023, then slumped by 65.79% to $26000.0 in 2024, then soared by 142.31% to $63000.0 in 2025, then slumped by 55.56% to $28000.0 in 2026.
- The last three Interest & Investment Income figures came in at $28000.0 (Q2 2026), $36000.0 (Q1 2026), and $63000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 7.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 4.99 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 3.16 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.03 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -19.30 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -210,000.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 12,909.62 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 28,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28,000.00 |
| Mar 31, 2026 | 36,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 92,000.00 |
| Jun 30, 2025 | 76,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 59,000.00 |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Sep 30, 2023 | 121,000.00 |
| Jun 30, 2023 | 157,000.00 |
| Mar 31, 2023 | 177,000.00 |
| Dec 31, 2022 | 143,000.00 |
| Sep 30, 2022 | 103,000.00 |
| Jun 30, 2022 | 31,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |